← Back to recalls
FDA DrugClass IINotable

FDA Recall: Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL

Date: 2026-03-04
Brand: LEO PHARMA INC
Category: Drug
FDA Class: Class II

Description

Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.

Hazard

Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.

Remedy

11,407 units

View original recall →
FDA Recall: Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL | RecallWatch